C&T is gathering facts and information related to an investigation of a potential class action lawsuit against Theranos, a blood testing laboratory. In October 2015, news reports broke that Theranos utilizes its finger-stick samples blood testing technology in only one test – a herpes test – despite its online menu advertising roughly 200 tests.
Recent reports have now suggested that Theranos’ laboratory practices may pose health risks to patients. Specifically, federal inspectors have found “deficient practices” at a Theranos Inc. laboratory that “pose immediate jeopardy to patient health and safe . . . .” The Centers for Medicare and Medicaid Services (“CMS”) has reported that an inspection completed in November 2015 at the company’s lab in California uncovered five major infractions that violate the federal law governing clinical labs. These infractions and deficiencies were set forth in a January 25 letter to Theranos. The agency identified one infraction as creating a situation “likely to cause, at any time, serious injury or harm, or death, to individuals served by the laboratory or to the health and safety of the general public.” One pathologist has now publicly stated that people who recently had a blood test at a Theranos facility should see their doctor. Theranos has until February 4 to address the deficiencies identified by CMS in its January 25 letter.
If you have paid for a blood test that was conducted at Theranos, please contact us by clicking the button below.
[accordion-item id=”item-1″ title=”Email us about this Case”]
[accordion-item id=”item-2″ title=”Alert me to Case updates”]
[widgets_on_pages id=”Email Alerts”]